New York A00115 requires the commissioner of health to report annually on the cost and cost increases of the ten most expensive prescription drugs.
New York A00115 amends the public health law to mandate that the commissioner of health include in annual reports information on the cost and cost increases of the ten prescription drugs on which the state spends the most money. The bill specifies that these drugs must have had their costs increase by fifty percent or more over the past five years or by ten percent or more during the previous calendar year.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.